medigraphic.com

2011, Número 5

<< Anterior Siguiente >>

Arch Med Actual Trac Gen Inf 2011; 3 (5)


Herpes Genital
Una actualización para el profesional

Meylan P

Idioma: Español
Referencias bibliográficas: 32
Paginas: 3-15
Archivo PDF: 215.38 Kb.


RESUMEN

El virus del herpes HSV-1 y VHS-2 generalmente infecta a la esfera genital y oral, respectivamente. Estos dos virus se derivan de un ancestro común, pero evolucionaron por separado de varios millones de años, adaptándose a estos sitios. Así, mientras que cada virus puede infectar a cualquiera de los sitios, el VHS-1 se reactiva de posición con frecuencia en la posición oral y genital HSV-2. Se tomó nota de los siguientes hechos, conocidos y nuevos o significativos en la epidemiología (culminación de la epidemia de HSV-2 a E.-U., el aumento de la proporción de HSV-1 en las infecciones genitales), clínica (extra-orales o lesiones extra-genital, la gravedad de la estomatitis herpética), diagnóstico (confusión herpes zoster en los territorios del trigémino o sagrado) y las infecciones de herpes genital (méritos relativos de los patrones de tratamiento supresor y episódica y la manteca el tratamiento de este último) y oral (efecto del tratamiento con el tratamiento de la gingivoestomatitis y herpes labial).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Roizmann BK, D.M.; Whitley,R.C. Herpes Simplex Viruses. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields Virology. 5 ed. Philadelphia, New York: Wolters Kluver/Lippincott Williams&Wilkins; 2007:2501-601.

  2. Whitley RJ, Roizman B. herpes simplex viruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. 3 ed. Washington DC: ASM Press; 2009:409-36.

  3. Meylan P. [Swiss recommendations for the management of gential herpers and herpes simplex virus infection of the neonate]. Rev Med Suisse. 2005;1(36):2315-6, 8-22, 24-6.

  4. Bunzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PR. Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study. BMC Infect Dis. 2004;4:10.

  5. McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Virus Res. 2006;117(1):90-104.

  6. Gentry GA, Lowe M, Alford G, Nevins R. Sequence analyses of herpesviral enzymes suggest an ancient origin for human sexual behavior. Proc Natl Acad Sci U S A. 1988;85(8):2658-61.

  7. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N.Engl.J.Med. 1987;316(23):1444-9.

  8. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964-73.

  9. Lowhagen GB, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm.Infect. 2000;76(3):179-82.

  10. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003;30(10):797-800.

  11. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect. 2009;85(6):416-9.

  12. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J.Infect.Dis. 2000;181(4):1454-7.

  13. Diamond C, Selke S, Ashley R, Benedetti J, Corey L. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm.Dis. 1999;26(4):221-5.

  14. Amir J, Harel L, Smetana Z, Varsano I. The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatr Dermatol. 1999;16(4):259-63.

  15. Lautenschlager S, Eichmann A. The heterogeneous clinical spectrum of genital herpes. Dermatology. 2001;202(3):211-9.

  16. Meylan S, Robert D, Estrade C, Grimbuehler V, Peter O, Meylan PR, et al. Real-time PCR for type-specific identification of herpes simplex in clinical samples: evaluation of type-specific results in the context of CNS diseases. J Clin Virol. 2008;41(2):87-91.

  17. Usatine RP, Tinitigan R. Nongenital herpes simplex virus. Am Fam Physician. 2010;82(9):1075-82.

  18. Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370(9605):2127-37.

  19. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect. 2001;77(4):232-7.

  20. Bryson YJ, Dillon M, Lovett M, Acuna G, Taylor S, Cherry JD, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N.Engl.J.Med. 1983;308(16):916-21.

  21. Fife KH, Barbarash RA, Rudolph T, DeGregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double- blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm.Dis. 1997;24(8):481-6.

  22. Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin.Infect.Dis. 2002;34(7):944-8.

  23. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin.Infect.Dis. 2002;34(7):958-62.

  24. Abudalu M, Tyring S, Koltun W, Bodsworth N, Hamed K. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. Clin Infect Dis. 2008;47(5):651-8.

  25. Fife KH, Almekinder J, Ofner S. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir. Sex Transm Dis. 2007;34(5):297-301.

  26. Wald A, Selke S, Warren T, Aoki FY, Sacks S, Diaz-Mitoma F, et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis. 2006;33(9):529-33.

  27. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350(1):11-20.

  28. Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ. 1997;314(7097):1800-3.

  29. Nasser M, Fedorowicz Z, Khoshnevisan MH, Shahiri Tabarestani M. Acyclovir for treating primary herpetic gingivostomatitis. Cochrane Database Syst Rev. 2008(4):CD006700.

  30. Spruance SL, Nett R, Marbury T, Wolff R, Johnson J, Spaulding T. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002;46(7):2238-43.

  31. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA. 1997;277(17):1374-9.

  32. Hull CM, Harmenberg J, Arlander E, Aoki F, Bring J, Darpo B, et al. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebocontrolled, patient-initiated clinical trial. J Am Acad Dermatol. 2010.




2020     |     www.medigraphic.com